78 related articles for article (PubMed ID: 15119295)
1. New nevirapine label underscores the risk for hepatotoxicity in key populations.
AIDS Clin Care; 2004 Mar; 16(3):24. PubMed ID: 15119295
[No Abstract] [Full Text] [Related]
2. Nevirapine precautions published.
AIDS Treat News; 2004 Feb; (398):5. PubMed ID: 15119290
[TBL] [Abstract][Full Text] [Related]
3. Appropriate use of nevirapine for long-term therapy.
Leith J; Piliero P; Storfer S; Mayers D; Hinzmann R
J Infect Dis; 2005 Aug; 192(3):545-6; author reply 546. PubMed ID: 15995971
[No Abstract] [Full Text] [Related]
4. Virammune and women in the news.
Emery C
Surviv News (Atlanta Ga); 2005; 16(2):10. PubMed ID: 16158512
[No Abstract] [Full Text] [Related]
5. Risk for immune-mediated liver reactions by nevirapine revisited.
Medrano J; Barreiro P; Tuma P; Vispo E; Labarga P; Blanco F; Soriano V
AIDS Rev; 2008; 10(2):110-5. PubMed ID: 18615121
[TBL] [Abstract][Full Text] [Related]
6. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.
Sanne I; Mommeja-Marin H; Hinkle J; Bartlett JA; Lederman MM; Maartens G; Wakeford C; Shaw A; Quinn J; Gish RG; Rousseau F
J Infect Dis; 2005 Mar; 191(6):825-9. PubMed ID: 15717255
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine (Viramune) strengthens warning on liver, skin toxicities.
AIDS Treat News; 2000 Nov; (355):3-5. PubMed ID: 12170998
[TBL] [Abstract][Full Text] [Related]
8. Third-trimester maternal toxicity with nevirapine use in pregnancy.
Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
[TBL] [Abstract][Full Text] [Related]
9. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
[No Abstract] [Full Text] [Related]
10. Comparing liver toxicity between efavirenz and nevirapine.
TreatmentUpdate; 2002 Feb; 14(2):7-8. PubMed ID: 12691044
[No Abstract] [Full Text] [Related]
11. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
[TBL] [Abstract][Full Text] [Related]
12. Side effects. Severe nevirapine rash found more likely in women than men.
TreatmentUpdate; 2001; 12(8):7. PubMed ID: 12132442
[No Abstract] [Full Text] [Related]
13. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
Arranz Caso JA; López JC; Santos I; Estrada V; Castilla V; Sanz J; Sanz J; Molina JP; Fernández Guerrero M; Górgolas M
HIV Med; 2005 Sep; 6(5):353-9. PubMed ID: 16156884
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine levels may predict toxicity.
TreatmentUpdate; 2002 Feb; 14(2):6-7. PubMed ID: 12691043
[No Abstract] [Full Text] [Related]
15. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.
Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE
AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443
[TBL] [Abstract][Full Text] [Related]
16. Negligence. Liver transplant patient too late to sue Viramune maker.
AIDS Policy Law; 2003 Mar; 18(6):7. PubMed ID: 12712930
[No Abstract] [Full Text] [Related]
17. Diffuse interstitial pulmonary opacities induced by nevirapine.
Sankatsing SU; Schouten WE
AIDS; 2007 Sep; 21(14):1993-4. PubMed ID: 17721119
[No Abstract] [Full Text] [Related]
18. Widespread vitiligo after erythroderma caused by nevirapine in a patient with AIDS.
Ramírez-Hernández M; Sánchez-Sierra B; Martínez-Escribano JA
Acta Derm Venereol; 2007; 87(5):442-3. PubMed ID: 17721659
[No Abstract] [Full Text] [Related]
19. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
[No Abstract] [Full Text] [Related]
20. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.
Phanuphak N; Apornpong T; Teeratakulpisarn S; Chaithongwongwatthana S; Taweepolcharoen C; Mangclaviraj S; Limpongsanurak S; Jadwattanakul T; Eiamapichart P; Luesomboon W; Apisarnthanarak A; Kamudhamas A; Tangsathapornpong A; Vitavasiri C; Singhakowinta N; Attakornwattana V; Kriengsinyot R; Methajittiphun P; Chunloy K; Preetiyathorn W; Aumchantr T; Toro P; Abrams EJ; El-Sadr W; Phanuphak P
HIV Med; 2007 Sep; 8(6):357-66. PubMed ID: 17661843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
